Predicted structure of agonist-bound glucagon-like peptide 1 receptor, a class B G protein-coupled receptor

Proceedings of the National Academy of Sciences of the United States of America

Volumn 109, Issue 49, 2012, Pages 19988-19993

  Kirkpatrick, Andrea ^a   Heo, Jiyoung ^a,b   Abrol, Ravinder ^a   Goddard III, William A ^a  

^a CALIFORNIA INSTITUTE OF TECHNOLOGY   (United States)

^b Sangmyung University   (South Korea)

Author keywords

Incretin receptors; Peptide hormones; Protein structure prediction

Indexed keywords

EXENDIN 4; GLUCAGON LIKE PEPTIDE 1 RECEPTOR;

AMINO TERMINAL SEQUENCE; ARTICLE; CRYSTAL STRUCTURE; DIABETES MELLITUS; DRUG DESIGN; HYDROGEN BOND; HYDROPHOBICITY; MOLECULAR DOCKING; MOLECULAR DYNAMICS; MUTAGENESIS; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; X RAY;

DRUG DESIGN; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; MODELS, MOLECULAR; PEPTIDES; PROTEIN CONFORMATION; PROTEIN INTERACTION DOMAINS AND MOTIFS; RECEPTORS, GLUCAGON; VENOMS;

EID: 84870606111     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1218051109     Document Type: Article

References (59)

1. Filmore D (2004) It's a GPCR world. Modern Drug Discovery 7(11):24-28.
2. Palczewski K, et al. (2000) Crystal structure of rhodopsin: A G protein-coupled receptor. Science 289(5480):739-745. (Pubitemid 30650186)
3. Cherezov V, et al. (2007) High-resolution crystal structure of an engineered human beta2-adrenergic G protein-coupled receptor. Science 318(5854):1258-1265. (Pubitemid 350172884)
4. Warne T, et al. (2008) Structure of a beta1-adrenergic G-protein-coupled receptor. Nature 454(7203):486-491.
5. Jaakola VP, et al. (2008) The 2.6 angstrom crystal structure of a human A2A adenosine receptor bound to an antagonist. Science 322(5905):1211-1217.
6. Chien EY, et al. (2010) Structure of the human dopamine D3 receptor in complex with a D2/D3 selective antagonist. Science 330(6007):1091-1095.
7. Wu B, et al. (2010) Structures of the CXCR4 chemokine GPCR with small-molecule and cyclic peptide antagonists. Science 330(6007):1066-1071.
8. Shimamura T, et al. (2011) Structure of the human histamine H1 receptor complex with doxepin. Nature 475(7354):65-70.
9. Haga K, et al. (2012) Structure of the human M2 muscarinic acetylcholine receptor bound to an antagonist. Nature 482(7386):547-551.
10. Kruse AC, et al. (2012) Structure and dynamics of the M3 muscarinic acetylcholine receptor. Nature 482(7386):552-556.
11. Hanson MA, et al. (2012) Crystal structure of a lipid G protein-coupled receptor. Science 335(6070):851-855.
12. Lagerström MC, Schiöth HB (2008) Structural diversity of G protein-coupled receptors and significance for drug discovery. Nat Rev Drug Discov 7(4):339-357.
13. Wu HX, et al. (2012) Structure of the human κ-opioid receptor in complex with JDTic. Nature 485(7398):327-332.
14. Manglik A, et al. (2012) Crystal structure of the μ-opioid receptor bound to a morphinan antagonist. Nature 485(7398):321-326.
15. Granier S, et al. (2012) Structure of the δ-opioid receptor bound to naltrindole. Nature 485(7398):400-404.
16. Thompson AA, et al. (2012) Structure of the nociceptin/orphanin FQ receptor in complex with a peptide mimetic. Nature 485(7398):395-399.
17. Parthier C, Reedtz-Runge S, Rudolph R, Stubbs MT (2009) Passing the baton in class B GPCRs: Peptide hormone activation via helix induction? Trends Biochem Sci 34(6):303-310.
18. Neumann JM, et al. (2008) Class-B GPCR activation: Is ligand helix-capping the key? Trends Biochem Sci 33(7):314-319.
19. Pal K, Melcher K, Xu HE (2012) Structure and mechanism for recognition of peptide hormones by Class B G-protein-coupled receptors. Acta Pharmacol Sin 33(3):300-311.
20. Schmidt WE, Siegel EG, Creutzfeldt W (1985) Glucagon-like peptide-1 but not glucagon- like peptide-2 stimulates insulin release from isolated rat pancreatic islets. Diabetologia 28(9):704-707. (Pubitemid 16226411)
21. Kieffer TJ, Habener JF (1999) The glucagon-like peptides. Endocr Rev 20(6):876-913. (Pubitemid 30647076)
22. Kieffer TJ, McIntosh CH, Pederson RA (1995) Degradation of glucose-dependent insulinotropic polypeptide and truncated glucagon-like peptide 1 in vitro and in vivo by dipeptidyl peptidase IV. Endocrinology 136(8):3585-3596.
23. Mentlein R, Gallwitz B, Schmidt WE (1993) Dipeptidyl-peptidase IV hydrolyses gastric inhibitory polypeptide, glucagon-like peptide-1(7-36)amide, peptide histidine methionine and is responsible for their degradation in human serum. Eur J Biochem 214(3):829-835. (Pubitemid 23188160)
24. Eng J, Kleinman WA, Singh L, Singh G, Raufman JP (1992) Isolation and characterization of exendin-4, an exendin-3 analogue, from Heloderma suspectum venom. Further evidence for an exendin receptor on dispersed acini from guinea pig pancreas. J Biol Chem 267(11):7402-7405.
25. Parkes DG, Pittner R, Jodka C, Smith P, Young A (2001) Insulinotropic actions of exendin- 4 and glucagon-like peptide-1 in vivo and in vitro. Metabolism 50(5):583-589. (Pubitemid 32433049)
26. Bray GM (2006) Exenatide. Am J Health Syst Pharm 63(5):411-418.
27. Göke R, et al. (1993) Exendin-4 is a high potency agonist and truncated exendin-(9-39)-amide an antagonist at the glucagon-like peptide 1-(7-36)-amide receptor of insulin-secreting beta-cells. J Biol Chem 268(26):19650-19655. (Pubitemid 23270754)
28. Elashoff M, Matveyenko AV, Gier B, Elashoff R, Butler PC (2011) Pancreatitis, pancreatic, and thyroid cancer with glucagon-like peptide-1-based therapies. Gastroenterology 141(1):150-156.
29. Vaidehi N, et al. (2002) Prediction of structure and function of G protein-coupled receptors. Proc Natl Acad Sci USA 99(20):12622-12627.
30. Runge S, Thøgersen H, Madsen K, Lau J, Rudolph R (2008) Crystal structure of the ligand-bound glucagon-like peptide-1 receptor extracellular domain. J Biol Chem 283 (17):11340-11347.
31. Abrol R, Griffith AR, Bray JK, Goddard WA, 3rd (2012) Structure prediction of g protein-coupled receptors and their ensemble of functionally important conformations. Methods Mol Biol 914:237-254.
32. Li Y, et al. (2007) Prediction of the 3D structure and dynamics of human DP G-protein coupled receptor bound to an agonist and an antagonist. J Am Chem Soc 129(35):10720-10731. (Pubitemid 350067482)
33. Kam VWT, Goddard WA (2008) Flat-bottom strategy for improved accuracy in protein side-chain placements. J Chem Theory Comput 4(12):2160-2169.
34. Grace CR, et al. (2007) Structure of the N-terminal domain of a type B1 G protein-coupled receptor in complex with a peptide ligand. Proc Natl Acad Sci USA 104(12):4858-4863. (Pubitemid 47186141)
35. Chen R, Li L, Weng ZP (2003) ZDOCK: An initial-stage protein-docking algorithm. Proteins 52(1):80-87. (Pubitemid 36648854)
36. Neidigh JW, Fesinmeyer RM, Prickett KS, Andersen NH (2001) Exendin-4 and glucagon- like-peptide-1: NMR structural comparisons in the solution and micelle-associated states. Biochemistry 40(44):13188-13200. (Pubitemid 33043533)
37. Eswar N, et al. (2006) Comparative protein structure modeling using Modeller. Current Protocols in Bioinformatics (Wiley, New York), Unit 5.6.
38. Phillips JC, et al. (2005) Scalable molecular dynamics with NAMD. J Comput Chem 26 (16):1781-1802. (Pubitemid 43078511)
39. MacKerell AD, et al. (1998) All-atom empirical potential for molecular modeling and dynamics studies of proteins. J Phys Chem B 102(18):3586-3616.
40. Brooks BR, et al. (2009) CHARMM: The biomolecular simulation program. J Comput Chem 30(10):1545-1614.
41. Jorgensen WL, Chandrasekhar J, Madura JD, Impey RW, Klein ML (1983) Comparison of simple potential functions for simulating liquid water. J Chem Phys 79(2):926-935.
42. Runge VM (2008) Notes on "Characteristics of gadolinium-DTPA complex: A potential NMR contrast agent" AJR Am J Roentgenol 190(6):1433-1434.
43. Ballesteros A, Weinstein H (1995) Integrated methods for the construction of three-dimensional models and computational probing of structure-function relations in G protein-coupled receptors. Methods Neurosci 25:366-428.
44. Vogel R, et al. (2008) Functional role of the "ionic lock" - an interhelical hydrogenbond network in family A heptahelical receptors. J Mol Biol 380(4):648-655.
45. Fortin JP, Schroeder JC, Zhu Y, Beinborn M, Kopin AS (2010) Pharmacological characterization of human incretin receptor missense variants. J Pharmacol Exp Ther 332 (1):274-280.
46. Heller RS, Kieffer TJ, Habener JF (1996) Point mutations in the first and third intracellular loops of the glucagon-like peptide-1 receptor alter intracellular signaling. Biochem Biophys Res Commun 223(3):624-632. (Pubitemid 26246123)
47. Takhar S, et al. (1996) The third cytoplasmic domain of the GLP-1[7-36 amide] receptor is required for coupling to the adenylyl cyclase system. Endocrinology 137(5): 2175-2178. (Pubitemid 26133992)
48. Rasmussen SG, et al. (2011) Crystal structure of the β2 adrenergic receptor-Gs protein complex. Nature 477(7366):549-555.
49. Katritch V, Cherezov V, Stevens RC (2012) Diversity and modularity of G protein-coupled receptor structures. Trends Pharmacol Sci 33(1):17-27.
50. Couvineau A, Laburthe M (2012) The family B1 GPCR: Structural aspects and interaction with accessory proteins. Curr Drug Targets 13(1):103-115.
51. Beinborn M, Worrall CI, McBride EW, Kopin AS (2005) A human glucagon-like peptide- 1 receptor polymorphism results in reduced agonist responsiveness. Regul Pept 130(1-2):1-6. (Pubitemid 40966015)
52. Coopman K, et al. (2011) Residues within the transmembrane domain of the glucagon- like peptide-1 receptor involved in ligand binding and receptor activation: Modelling the ligand-bound receptor. Mol Endocrinol 25(10):1804-1818.
53. Underwood CR, et al. (2010) Crystal structure of glucagon-like peptide-1 in complex with the extracellular domain of the glucagon-like peptide-1 receptor. J Biol Chem 285(1):723-730.
54. López de Maturana R, Treece-Birch J, Abidi F, Findlay JB, Donnelly D (2004) Met-204 and Tyr-205 are together important for binding GLP-1 receptor agonists but not their N-terminally truncated analogues. Protein Pept Lett 11(1):15-22. (Pubitemid 38345499)
55. Al-Sabah S, Donnelly D (2003) A model for receptor-peptide binding at the glucagonlike peptide-1 (GLP-1) receptor through the analysis of truncated ligands and receptors. Br J Pharmacol 140(2):339-346. (Pubitemid 37249194)
56. López de Maturana R, Donnelly D (2002) The glucagon-like peptide-1 receptor binding site for the N-terminus of GLP-1 requires polarity at Asp198 rather than negative charge. FEBS Lett 530(1-3):244-248. (Pubitemid 35248219)
57. Koole C, et al. (2012) Second extracellular loop of human glucagon-like peptide-1 receptor (GLP-1R) has a critical role in GLP-1 peptide binding and receptor activation. J Biol Chem 287(6):3642-3658.
58. Hoare SR (2005) Mechanisms of peptide and nonpeptide ligand binding to Class B G-protein-coupled receptors. Drug Discov Today 10(6):417-427.
59. Knudsen LB, et al. (2007) Small-molecule agonists for the glucagon-like peptide 1 receptor. Proc Natl Acad Sci USA 104(3):937-942. (Pubitemid 46154715)